Abbvie (ABBV) Shareholder Huber Capital Management Has Lifted Position by $720,000 as Share Value Declined; Westover Capital Advisors Increased Stake in Visa (V) by $568,997

Visa Inc. (NYSE:V) Logo

Huber Capital Management Llc increased its stake in Abbvie Inc (ABBV) by 69.75% based on its latest 2019Q2 regulatory filing with the SEC. Huber Capital Management Llc bought 10,000 shares as the company’s stock declined 15.55% . The hedge fund held 24,337 shares of the major pharmaceuticals company at the end of 2019Q2, valued at $1.77 million, up from 14,337 at the end of the previous reported quarter. Huber Capital Management Llc who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $108.04 billion market cap company. The stock increased 1.31% or $0.97 during the last trading session, reaching $74.82. About 3.37 million shares traded. AbbVie Inc. (NYSE:ABBV) has declined 27.15% since October 4, 2018 and is downtrending. It has underperformed by 27.15% the S&P500. Some Historical ABBV News: 09/04/2018 - Merck’s Keytruda meets main goal in lung cancer trial; 09/04/2018 - ABBVIE INC - ALL RANKED SECONDARY ENDPOINTS ALSO MET IN PHASE 3 STUDY IN RHEUMATOID ARTHRITIS; 02/04/2018 - Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients with Pegzilarginase in Both Monotherapy and KEYTRUDA® (Pemb; 09/04/2018 - ABBVIE: UPADACITINIB MEETS ALL PRIMARY, SECONDARY ENDPOINTS; 28/03/2018 - IMMUNOVACCINE ANNOUNCES INITIATION OF PATIENT DOSING IN INVESTIGATOR-SPONSORED PHASE 2 CLINICAL TRIAL OF ITS LEAD CANDIDATE DPX-SURVIVAC USED IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH DLBCL; 14/05/2018 - CLINTON GROUP BOOSTED AVY, ABBV, FB, CAG, VIAB IN 1Q: 13F; 24/04/2018 - ELI LILLY - 2018 REV GROWTH ALSO EXPECTED TO BE DRIVEN BY NEW PRODUCTS INCLUDING VERZENIO, CYRAMZA, OLUMIANT, LARTRUVO; 26/04/2018 - ABBVIE INC - QTRLY GAAP SHR $1.74; QTRLY ADJ. SHR $1.87; QTRLY WORLDWIDE NET REVENUE $7.93 BLN, UP 21.4 PCT ON GAAP BASIS; 26/04/2018 - MOODY’S: ABBVIE’S SHR REPURCHASE ACCELERATION CREDIT NEGATIVE; 16/05/2018 - Merck’s Keytruda boosts response in hard-to-treat lung cancer

Westover Capital Advisors Llc increased its stake in Visa Inc (V) by 173.75% based on its latest 2019Q2 regulatory filing with the SEC. Westover Capital Advisors Llc bought 3,289 shares as the company’s stock rose 9.34% . The institutional investor held 5,182 shares of the business services company at the end of 2019Q2, valued at $899,000, up from 1,893 at the end of the previous reported quarter. Westover Capital Advisors Llc who had been investing in Visa Inc for a number of months, seems to be bullish on the $394.33B market cap company. The stock increased 1.82% or $3.14 during the last trading session, reaching $176.01. About 3.13M shares traded. Visa Inc. (NYSE:V) has risen 30.42% since October 4, 2018 and is uptrending. It has outperformed by 30.42% the S&P500. Some Historical V News: 25/04/2018 - Visa 2Q Net $2.6B; 24/04/2018 - Visa Presenting at Conference May 15; 24/05/2018 - Retailers Say Visa, Mastercard Pressing the Wrong Button; 15/04/2018 - UK MARCH VISA CONSUMER SPENDING -2.1 PCT YY VS FEB -1.0 PCT YY, BIGGEST FALL SINCE OCT 2017; 04/05/2018 - Visa wins “Best Credit Card” for Hong Kong travellers in the 2018 TripAdvisor Travellers’ Favourites; 30/05/2018 - U.S. Toughens Visa Process for Chinese Nationals; 10/05/2018 - Congress Pressuring Homeland Security to Boost the Visa Supply Soon; 25/04/2018 - VISA INC QTRLY TOTAL PROCESSED TRANSACTIONS, REPRESENTING TRANSACTIONS PROCESSED BY VISA, WERE 29.3 BILLION, A 12% INCREASE OVER THE PRIOR YEAR; 22/03/2018 - Rep. Matsui: GAO Releases Matsui-Requested Study of Special Immigrant Visa Holder Resettlement Process; 28/05/2018 - Canada Intends to Lift Visa Requirement on the United Arab Emirates

More notable recent Visa Inc. (NYSE:V) news were published by: Seekingalpha.com which released: “Visa: Valuation Follow-Up - Seeking Alpha” on September 26, 2019, also Marketwatch.com with their article: “Visa stock the biggest drag on the Dow, as payments sector suffers broad decline - MarketWatch” published on September 09, 2019, Seekingalpha.com published: “Expected Dividend Increases In October 2019 - Seeking Alpha” on October 04, 2019. More interesting news about Visa Inc. (NYSE:V) were released by: Seekingalpha.com and their article: “Load Up On Visa - Seeking Alpha” published on August 14, 2019 as well as Fool.com‘s news article titled: “Should Visa Worry About Apple’s New Credit Card? - Motley Fool” with publication date: September 12, 2019.

Investors sentiment decreased to 0.94 in 2019 Q2. Its down 0.11, from 1.05 in 2019Q1. It worsened, as 43 investors sold V shares while 678 reduced holdings. 144 funds opened positions while 531 raised stakes. 1.53 billion shares or 0.66% less from 1.54 billion shares in 2019Q1 were reported. Blue Capital holds 34,157 shares. South Texas Money Mgmt Limited holds 0.02% or 2,708 shares. Nuveen Asset Lc has invested 1.11% in Visa Inc. (NYSE:V). Caisse De Depot Et Placement Du Quebec has 0.02% invested in Visa Inc. (NYSE:V) for 49,551 shares. Stearns Financial Group Inc holds 5,716 shares or 0.18% of its portfolio. Cantillon Management Lc invested in 2.67 million shares or 4.67% of the stock. Osterweis Incorporated owns 1.86% invested in Visa Inc. (NYSE:V) for 151,668 shares. Guggenheim Limited Liability Corporation holds 0.39% or 277,374 shares in its portfolio. South Street Advsrs Limited Liability Company has 95,743 shares. Northside Capital Ltd Liability Corp reported 12,760 shares. Coldstream Cap Incorporated has 0.37% invested in Visa Inc. (NYSE:V). Moreover, Chase Inv Counsel has 3.73% invested in Visa Inc. (NYSE:V) for 42,232 shares. Plante Moran Fincl Advisors Lc owns 9,330 shares. Qci Asset Management owns 1,590 shares or 0.03% of their US portfolio. Echo Street Cap Ltd Limited Liability Company holds 0.68% of its portfolio in Visa Inc. (NYSE:V) for 223,470 shares.

Since August 6, 2019, it had 1 insider purchase, and 0 sales for $171,130 activity.

Westover Capital Advisors Llc, which manages about $162.39M and $202.58 million US Long portfolio, decreased its stake in Fedex Corp (NYSE:FDX) by 12,881 shares to 4,844 shares, valued at $795,000 in 2019Q2, according to the filing. It also reduced its holding in Dollar Gen Corp New (NYSE:DG) by 2,284 shares in the quarter, leaving it with 29,841 shares, and cut its stake in Southwest Airls Co (NYSE:LUV).

Investors sentiment increased to 1.16 in Q2 2019. Its up 0.33, from 0.83 in 2019Q1. It is positive, as 67 investors sold ABBV shares while 513 reduced holdings. 129 funds opened positions while 542 raised stakes. 950.66 million shares or 1.26% less from 962.74 million shares in 2019Q1 were reported. Goelzer Inv Inc reported 55,779 shares or 0.37% of all its holdings. Novare Mgmt Limited Liability Company has invested 0.63% in AbbVie Inc. (NYSE:ABBV). 5,340 were reported by Tiverton Asset Management Ltd. Benedict Fincl Advsr accumulated 3,046 shares or 0.09% of the stock. Alexandria Cap Lc reported 0.07% stake. Financial Counselors invested in 0.73% or 246,575 shares. Omers Administration Corporation has invested 0.07% in AbbVie Inc. (NYSE:ABBV). Mcrae Mgmt invested in 3,117 shares or 0.09% of the stock. Moreover, Los Angeles Capital Equity Research has 0.25% invested in AbbVie Inc. (NYSE:ABBV) for 647,397 shares. Cornercap Investment Counsel Incorporated has invested 0.44% in AbbVie Inc. (NYSE:ABBV). Moreover, Mitchell Sinkler & Starr Pa has 2.02% invested in AbbVie Inc. (NYSE:ABBV) for 24,306 shares. Private Wealth Prtn Ltd Liability Co holds 0.06% or 5,250 shares in its portfolio. Meyer Handelman Communication has 0.39% invested in AbbVie Inc. (NYSE:ABBV). Moreover, Hgk Asset Mgmt has 1.37% invested in AbbVie Inc. (NYSE:ABBV). Dupont Cap Mgmt Corp holds 0.08% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 47,247 shares.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Fool.com which released: “2 Pharma Stocks You Should Buy Now - The Motley Fool” on September 21, 2019, also Finance.Yahoo.com with their article: “Gilead Tops List of Most Innovative Drug Companies - Yahoo Finance” published on September 12, 2019, Investorplace.com published: “7 Big Biotech Stocks to Watch - Investorplace.com” on September 27, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “Allergan: Why I Like This AbbVie Target - Seeking Alpha” published on September 05, 2019 as well as Schaeffersresearch.com‘s news article titled: “Straddle Traders Just Won Big on This Volatility Bet - Schaeffers Research” with publication date: September 26, 2019.

Huber Capital Management Llc, which manages about $3.94B and $841.43M US Long portfolio, decreased its stake in Allergan Plc by 2,800 shares to 16,500 shares, valued at $2.76 million in 2019Q2, according to the filing. It also reduced its holding in Exelon Corp (NYSE:EXC) by 207,712 shares in the quarter, leaving it with 347,200 shares, and cut its stake in Nxp Semiconductors N V (NASDAQ:NXPI).

Visa Inc. (NYSE:V) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.